Pramlintide inhibits the growth of HCT-116 and HT-29 in a dose-dependent manner, with higher efficacy against the latter (IC
50
s of 48.67 and 9.10 μg/mL, respectively).
The addition of 5, 10, and 20 μg/mL of Pramlintide to HCT-116 and HT-29 with 5-fluorouracil, Oxaliplatin, or Irinotecan induces the antiproliferative effect synergistically.
中文
CAS号:120287-85-6
CAS号:158861-67-7
CAS号:183552-38-7
CAS号:145781-92-6
CAS号:66002-66-2
CAS号:34973-08-5
CAS号:28575-34-0
CAS号:3397-23-7
CAS号:114466-38-5
CAS号:116430-60-5
CAS号:60189-34-6
CAS号:140194-24-7
CAS号:86220-42-0
CAS号:57982-77-1